InsidersTradesSigma
Browse the full record of transactions filed by Campoy Carlos, Chief Financial Officer. Insider active across 1 companies, notably CytomX Therapeutics, Inc.. Cumulatively, 4 reports have been published. The latest transaction was filed on 2 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
Carlos Campoy is the Chief Financial Officer of CytomX Therapeutics, Inc. In this role, he is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. Campoy works closely with management to ensure the financial health of the company and support its growth strategy.